Zinc chloride (ZnCl2) is used as a common source of zinc supplement in the pharmaceutical and nutraceutical formulations. In this experiment, the impact of the Trivedi Effect®- Consciousness Energy Healing Treatment on the physicochemical, thermal, and behavioral properties of ZnCl2 was evaluated using sophisticated analytical techniques. The test sample ZnCl2 was divided into two parts. One part of ZnCl2 was considered as a control sample (no Biofield Treatment was provided), while second part received the Trivedi Effect®-Consciousness Energy Healing Treatment remotely by a famous Biofield Energy Healer, Alice Branton and termed as treated ZnCl2. The powder XRD crystallite sizes and peak intensities of the treated ZnCl2 were significantly altered ranging from -16.67% to 99.97% and -88.51% to 202.23%, respectively; however, the average crystallite size was significantly increased by 14.14% compared with the control sample. The particles size values of the treated ZnCl2 at d10, d50, and d90 and D (4,3) were significantly increased by 886.20%, 36.70%, 28.90%, and 92.71%, respectively compared to the control sample. Hence, the surface area of the treated ZnCl2 was significantly decreased by 81.16% compared with the control ZnCl2. The latent heat of fusion of the treated ZnCl2 was significantly increased by 26.48% compared with the control sample. However, the latent heat of decomposition of the treated ZnCl2 was significantly decreased by 85.20% compared with the control sample. The study results anticipated that the Trivedi Effect®-Consciousness Energy Healing Treatment might produce a new polymorphic form of ZnCl2 with larger crystallite and particle size and reduced surface area, which would improve the flowability, shape, and appearance compared with the control sample. The Biofield Energy Treated ZnCl2 would be very useful to design more efficacious nutraceutical or pharmaceutical formulations against cancer, inflammatory diseases, stress, immunological disorders, aging, Parakeratosis, dysosmia, anorexia, hypogeusia, hypogonadism, Wilson’s disease, etc.